Table 2 Zika virus CD4 peptide selection based on multiparameters using immunoinformatics tools.
From: In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools
Protein | Epitope | Size (aa) | Position | Nº of alleles1 | % of total alleles2 | Immunogenicity (Percentile Rank)3 | Nº of HLAs w/Percentile Rank < 204 | Nº of HLAs w/ SMM align IC50 < 500 nM5 | Nº of HLAs w/NN align IC50 < 500nM6 | IFNepitope Score (SVM)7 |
---|---|---|---|---|---|---|---|---|---|---|
Capsid Protein | HGPIRMVLAILAFLR (C_41-55) | 15 | 41–55 | 37 | 72.54 | 24.3268 | 21 | 17 | 14 | 0.4521 |
prM Protein | TTSTWVVYGTCHHKK (prM_71-85) | 15 | 71–85 | 31 | 60.8 | 65.45964 | 4 | 0 | 2 | − 0.1269 |
Envelope Protein E | EYRIMLSVHGSQHSG (E_136-150) | 15 | 136–150 | 33 | 64.7 | 40.45516 | 13 | 9 | 12 | − 0.1841 |
Envelope Protein E | DKLRLKGVSYSLCTA (E_296-310) | 15 | 296–310 | 34 | 66.6 | 46.33096 | 12 | 2 | 12 | − 0.3609 |
NS1 | SYFVRAAKTNNSFVV (NS1_121-135) | 15 | 121–135 | 30 | 58.8 | 31.18672 | 11 | 12 | 12 | 0.3363 |
NS2A | PFVMALGLTAVRLVD (NS2A_196-210) | 15 | 196–210 | 29 | 56.8 | 42.90484 | 17 | 11 | 14 | 0.2505 |
NS2B | FAAGAWYVYVKTGKR (NS2B_116-130) | 15 | 116–130 | 11 | 27.50 | 42.51056 | 14 | 5 | 9 | 0.5012 |
NS3 | LRGLPVRYMTTAVNV (NS3_236-250) | 15 | 236–250 | 35 | 68.6 | 43.8254 | 12 | 8 | 13 | 0.4513 |
NS4A | LGIFFVLMRNKGIGK (NS4A_66-80) | 15 | 66–80 | 40 | 78.4 | 25.47468 | 21 | 10 | 14 | 0.0979 |
NS4B | HYMYLIPGLQAAAAR (NS4B_119-133) | 15 | 119–133 | 18 | 35.29 | 42.61168 | 19 | 10 | 14 | 0.0579 |
NS4B | VAVSSAILSRTAWGW (NS4B_178-192) | 15 | 178–192 | 38 | 74.5 | 49.2798 | 13 | 6 | 6 | 0.3106 |
NS5 | LLYFHRRDLRLMANA (NS5_766-780) | 15 | 766–780 | 36 | 70.6 | 38.39304 | 20 | 8 | 12 | 0.2457 |